A. Coates

1.7k total citations · 1 hit paper
19 papers, 1.3k citations indexed

About

A. Coates is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, A. Coates has authored 19 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in A. Coates's work include Cancer Treatment and Pharmacology (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Blood properties and coagulation (4 papers). A. Coates is often cited by papers focused on Cancer Treatment and Pharmacology (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Blood properties and coagulation (4 papers). A. Coates collaborates with scholars based in United States, Australia and United Kingdom. A. Coates's co-authors include Steinar Aamdal, Uwe Fraass, Simone Seiter, Wolfgang Tilgen, Neil K. Aaronson, Martin Gore, Jonathan Cebon, Amy V. Kapp, N. Thatcher and Dirk Schadendorf and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

A. Coates

19 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma

2000 936 citations Mark R. Middleton, Jean‐Jacques Grob et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Coates United States	11	802	678	246	245	123	19	1.3k
Mohammed M. Dar United States	19	820 1.0×	891 1.3×	336 1.4×	280 1.1×	184 1.5×	42	1.7k
Thomas Holbro Switzerland	11	1.3k 1.6×	1.3k 1.9×	196 0.8×	300 1.2×	209 1.7×	17	2.3k
Denis M. Collins Ireland	20	671 0.8×	479 0.7×	139 0.6×	210 0.9×	156 1.3×	53	1.2k
Erika von Euw United States	18	757 0.9×	893 1.3×	353 1.4×	269 1.1×	209 1.7×	30	1.6k
Martin L. Campbell United States	13	515 0.6×	805 1.2×	116 0.5×	403 1.6×	232 1.9×	18	1.4k
Takahito Nakahara Japan	13	496 0.6×	947 1.4×	174 0.7×	153 0.6×	109 0.9×	21	1.2k
Wanleng Deng United States	14	659 0.8×	907 1.3×	171 0.7×	272 1.1×	236 1.9×	20	1.4k
Bo‐Sheng Pan United States	11	290 0.4×	1.1k 1.6×	206 0.8×	226 0.9×	139 1.1×	16	1.6k
Harold Hatch United States	7	346 0.4×	1.1k 1.6×	189 0.8×	277 1.1×	165 1.3×	7	1.4k
Martina Rahmeh Germany	13	677 0.8×	476 0.7×	96 0.4×	197 0.8×	140 1.1×	22	1.2k

Countries citing papers authored by A. Coates

Since Specialization

Citations

This map shows the geographic impact of A. Coates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Coates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Coates more than expected).

Fields of papers citing papers by A. Coates

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Coates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Coates. The network helps show where A. Coates may publish in the future.

Co-authorship network of co-authors of A. Coates

This figure shows the co-authorship network connecting the top 25 collaborators of A. Coates. A scholar is included among the top collaborators of A. Coates based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Coates. A. Coates is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Asahina, Hajime, Yosuke Tamura, Hiroshi Nokihara, et al.. (2012). An open-label, phase 1 study evaluating safety, tolerability, and pharmacokinetics of linifanib (ABT-869) in Japanese patients with solid tumors. Cancer Chemotherapy and Pharmacology. 69(6). 1477–1486. 19 indexed citations

Tannir, Nizar M., Christian Kollmannsberger, Marc S. Ernstoff, et al.. (2011). Phase 2 trial of linifanib (ABT-869) in patients with advanced renal cell cancer after sunitinib failure. European Journal of Cancer. 47(18). 2706–2714. 24 indexed citations

Rudin, Charles M., Ann M. Mauer, Martin Šmakal, et al.. (2011). Phase I/II Study of Pemetrexed With or Without ABT-751 in Advanced or Metastatic Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 29(8). 1075–1082. 42 indexed citations

Mauer, Ann M., Ezra E.W. Cohen, C. Patrick, et al.. (2008). A Phase II Study of ABT-751 in Patients with Advanced Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 3(6). 631–636. 78 indexed citations

Eliopoulos, Helen, Nashat Gabrail, A. Coates, et al.. (2007). P2-251: Phase 1/2 study evaluating the safety and efficacy of ABT-751 in combination with docetaxel vs docetaxel alone in subjects with advanced or metastatic non-small-cell lung cancer. Journal of Thoracic Oncology. 2(8). S672–S672. 1 indexed citations

Benson, Alice, Hedy L. Kindler, A. Hagey, et al.. (2005). Phase 2 study of ABT-751 in patients with refractory metastatic colorectal carcinoma (CRC). Journal of Clinical Oncology. 23(16_suppl). 3537–3537. 6 indexed citations

Mauer, Ann M., Livia L. Szeto, Robert J. Belt, et al.. (2005). Preliminary results of a phase 2 study of ABT-751 in patients (pts) with taxane-refractory non-small cell lung carcinoma (NSCLC). Journal of Clinical Oncology. 23(16_suppl). 7137–7137. 5 indexed citations

Kobayashi, Hanako, Kenneth R. Hande, Jordan Berlin, et al.. (2004). Phase I results of ABT-751, a novel microtubulin inhibitor, administered daily × 7 every 3 weeks. Journal of Clinical Oncology. 22(14_suppl). 2079–2079. 1 indexed citations

Kobayashi, Hirokazu, Kenneth R. Hande, Beat Roth, et al.. (2004). Phase I results of ABT-751, a novel microtubulin inhibitor, administered daily × 7 every 3 weeks. Journal of Clinical Oncology. 22(14_suppl). 2079–2079. 7 indexed citations

10.

Lefkowitz, Jerry B., et al.. (2001). Fibrinogen Longmont. A heterozygous abnormal fibrinogen with B beta Arg-166 to Cys substitution associated with defective fibrin polymerization.. PubMed. 936. 129–32. 5 indexed citations

11.

Lefkowitz, Jerry B., et al.. (2001). The impaired polymerization of fibrinogen Longmont (Bβ166Arg→Cys) is not improved by removal of disulfide-linked dimers from a mixture of dimers and cysteine-linked monomers. Blood. 98(3). 661–666. 20 indexed citations

12.

Lefkowitz, Jerry B., et al.. (2001). Fibrinogen Longmont. Annals of the New York Academy of Sciences. 936(1). 129–132. 6 indexed citations

13.

Middleton, Mark R., Jean‐Jacques Grob, Neil K. Aaronson, et al.. (2000). Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma. Journal of Clinical Oncology. 18(1). 158–158. 936 indexed citations breakdown →

14.

Hogan, Kelly A., Oleg V. Gorkun, A. Coates, et al.. (2000). Recombinant Fibrinogen Vlissingen/Frankfurt IV. Journal of Biological Chemistry. 275(23). 17778–17785. 27 indexed citations

15.

Colleoni, Marco, K. Price, Monica Castiglione‐Gertsch, et al.. (1998). Dose–response effect of adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in node-positive breast cancer. European Journal of Cancer. 34(11). 1693–1700. 51 indexed citations

16.

Coates, A., et al.. (1998). Dependence of heme accessibility in horseradish peroxidase on Ca2+. Journal of Inorganic Biochemistry. 72(1-2). 63–69. 9 indexed citations

17.

Hedley, David W., Angus Dalgleish, Derek Raghavan, et al.. (1984). ADVANCED BREAST CANCER: RESPONSE TO HIGH DOSE ORAL MEDROXYPROGESTERONE ACETATE. Australian and New Zealand Journal of Medicine. 14(3). 251–254. 13 indexed citations

18.

Arme, C. & A. Coates. (1973). Hymenolepis diminuta: Active transport of α-aminoisobutyric acid by cysticercoid larvae. International Journal for Parasitology. 3(4). 553–560. 17 indexed citations

19.

Arme, C. & A. Coates. (1971). Active Transport of an Amino Acid by Cysticercoid Larvae of Hymenolepis diminuta. Journal of Parasitology. 57(6). 1369–1369. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact